Defining a new oncogenic role for the promyelocytic leukemia (PML) protein in lung cancer.

The Operating Grants Program is the principal means by which the Cancer Research Society (CRS) fulfills its mission to support fundamental, early translational and environment-cancer research on all types of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease.